SCHEMBL7499158

SCHEMBL7499158

CC(=O)N(N)C(=O)c1ccc(Cl)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.55
DAO P14920 1/20 0.50
ALDH1A1 P00352 8/20 0.49
GAA P10253 3/20 0.46
KDM4E B2RXH2 3/20 0.46
GSK3B P49841 1/20 0.46
MAPK1 P28482 3/20 0.43
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
ALOX12 P18054 2/20 0.39
AHR P35869 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11201725 0.77 ALDH1A1 (0.59) F2DAOALDH1A1GAAKDM4E
SCHEMBL6653282 0.77 F2 (0.49) F2DAOALDH1A1GAAKDM4E
SCHEMBL3492 0.74
SCHEMBL92875 0.72
SCHEMBL6169358 0.71 ALDH1A1 (0.50) F2DAOALDH1A1GAAKDM4E
Hydrochloric Acid SCHEMBL31078723 0.70 F2 (0.95) F2DAOALDH1A1GAAKDM4E
SCHEMBL9144815 0.69 F2 (0.70) F2DAOALDH1A1GAAKDM4E
SCHEMBL27921277 0.69 CES2 (0.55) DAOALDH1A1GSK3BKMT2AMEN1
SCHEMBL14838703 0.68 F2 (0.46) F2DAOALDH1A1GAAKDM4E
SCHEMBL23074375 0.68 F2 (0.55) F2DAOALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1420882-A Substd. oxoazaheterocyclyl compounds AVENTIS PHARM PROD INC (US) 2003-05-28 CN disclosed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed